FOLD Earnings History

Amicus Therapeutics, Inc. (FOLD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.55B, listed on NASDAQ, employing roughly 499 people, carrying a beta of 0.48 to the broader market. Amicus Therapeutics, Inc. Led by Bradley L. Campbell, public since 2007-05-31.

Amicus Therapeutics, Inc. has beat EPS estimates in 2 of the last 6 quarters.

DateEPS Est.EPS ActualSurpriseRevenue Est.Revenue Actual
May 7, 20260.05N/AN/A$163.7MN/A
Feb 20, 20260.070.01N/A$180.5M$185.2M
Nov 4, 20250.120.17N/A$185.0M$169.1M
Jul 31, 20250.020.01N/A$165.3M$154.7M
May 1, 20250.080.03N/A$147.5M$125.2M
Feb 19, 20250.020.09N/A$147.9M$149.7M

What FOLD's Earnings History Tells Options Traders

Amicus Therapeutics, Inc. has missed estimates more often than it has beat them (only 2 beats in 6 reports). Names with poor beat-rate history typically carry richer downside skew going into earnings and produce larger post-event moves on misses, conditions where put-spread or long-vol structures may carry edge over premium-selling. Beat rate is one input to event-driven sizing; pair it with the implied-vs-realized volatility view, the current IV rank, and the put-call skew going into the print. Surprise magnitude matters as much as direction - an in-line beat with conservative guidance can produce a larger negative move than a missed quarter with raised forward guidance. The earnings table above shows the most recent six reported quarters; for the full multi-year history including revenue growth trajectory and EPS guidance trends, the per-ticker fundamentals view aggregates the underlying GAAP filings.

How Earnings Drive FOLD Options Pricing

Earnings events are the largest single driver of single-name implied volatility in equity options markets. Pre-event, IV inflates over the two-to-three week run-up as the binary uncertainty of the print compounds; the IV rank typically peaks the day before the announcement. Post-event, IV crushes back toward the realized-volatility baseline as uncertainty resolves. The magnitude of the crush depends on how stretched pre-event IV was relative to the eventual realized move - an oversized pre-event IV with an undersized realized move produces the cleanest premium-selling outcome, while a stretched IV that still under-prices a tail move on the print produces the cleanest long-vol outcome.

The catalyst calendar for FOLD matters beyond the headline EPS surprise. Forward guidance revisions, capital-allocation changes (dividend hikes, buyback authorizations, M&A announcements), and segment-level performance discussions can drive larger post-event moves than the headline beat or miss. Pair the earnings beat-rate read above with the upcoming-event calendar and the IV-rank view to size pre-event and post-event positioning; for short-vol structures the goal is to be long premium-rich and to harvest the IV crush, while for long-vol structures the goal is to own gamma cheap into a regime where the realized move is likely to exceed the implied move.